Compounded Semaglutide Safety Concerns Highlighted Amid Regulatory Gaps

Compounded semaglutide poses higher risks than FDA-approved versions due to less stringent regulatory oversight, despite potential safety from licensed pharmacies. The FDA has repeatedly warned consumers about unverified suppliers and issues like contamination or incorrect dosing. Patients should verify pharmacy legitimacy, as most insurance plans do not cover these products.